PARBOLD SURGERY — All Prescriptions & Medications — Page 9
Practice Code: P81096 | WIGAN, WN8 7DN
Showing results 401-450 of 572
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Testosterone esters | 24 | 42 | £98 | +62.7% ▲ |
| Other phosphate supplement preparations | 24 | 1,440 | £274 | +293.3% ▲ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 24 | 74.4K | £2.2K | -9.6% ▼ |
| Dexamethasone | 24 | 269 | £130 | -59.8% ▼ |
| 24 | 240 | £659 | -49.8% ▼ | |
| Lormetazepam | 23 | 494 | £155 | +95.3% ▲ |
| Lisdexamfetamine dimesylate | 23 | 650 | £1.5K | -80.7% ▼ |
| Oxcarbazepine | 23 | 1,990 | £414 | -17.8% ▼ |
| Ciprofloxacin | 23 | 528 | £81 | -42.3% ▼ |
| Triptorelin embonate | 23 | 23 | £8.8K | +131.0% ▲ |
| Magnesium aspartate | 23 | 349 | £314 | +51.9% ▲ |
| Midazolam hydrochloride | 23 | 225 | £124 | -43.8% ▼ |
| 23 | 705 | £1.6K | +46.5% ▲ | |
| Theophylline | 22 | 1,232 | £623 | -73.7% ▼ |
| Codeine phosphate | 22 | 7,700 | £259 | +53.3% ▲ |
| Sodium feredetate | 22 | 7,700 | £220 | -23.2% ▼ |
| Etoricoxib | 22 | 644 | £314 | -72.7% ▼ |
| Febuxostat | 22 | 728 | £57 | -41.1% ▼ |
| Ciclosporin (Eye Anti Inflammatory) | 22 | 1,080 | £2.6K | -11.3% ▼ |
| Bempedoic acid/Ezetimibe | 21 | 700 | £1.3K | -65.6% ▼ |
| Levocetirizine | 21 | 858 | £110 | +34.8% ▲ |
| Tamsulosin and dutasteride hydrochloride | 21 | 630 | £288 | -39.9% ▼ |
| Mefenamic acid | 21 | 1,612 | £306 | -53.5% ▼ |
| Ivermectin | 21 | 1,035 | £600 | -1.2% vs avg |
| 21 | 3,200 | £101 | -16.5% ▼ | |
| 21 | 49 | £1.1K | +105.9% ▲ | |
| Cimetidine | 20 | 1,154 | £106 | +7.2% ▲ |
| Tiotropium bromide/olodaterol | 20 | 20 | £618 | -67.4% ▼ |
| Rizatriptan | 20 | 216 | £388 | -66.4% ▼ |
| Perampanel | 20 | 742 | £3.5K | -7.7% ▼ |
| Glucose | 20 | 3,310 | £294 | -61.5% ▼ |
| Lidocaine | 20 | 435 | £373 | +74.0% ▲ |
| 20 | 27 | £528 | -70.8% ▼ | |
| Zuclopenthixol decanoate | 19 | 38 | £111 | +18.3% ▲ |
| Avanafil | 19 | 104 | £365 | +202.8% ▲ |
| Ready to serve 1.5 kcal/ml milkshake with fibre (0913021) | 19 | 120.0K | £3.2K | +37.6% ▲ |
| 19 | 74 | £825 | -38.7% ▼ | |
| 19 | 250 | £83 | +47.2% ▲ | |
| Sodium citrate (Rectal) | 18 | 177 | £118 | +30.4% ▲ |
| Labetalol hydrochloride | 18 | 1,568 | £196 | -20.7% ▼ |
| Telmisartan | 18 | 1,344 | £403 | -69.0% ▼ |
| Medroxyprogesterone acetate | 18 | 1,530 | £213 | -53.0% ▼ |
| Testosterone undecanoate | 18 | 24 | £2.0K | -29.1% ▼ |
| Meloxicam | 18 | 980 | £25 | -72.8% ▼ |
| Tafluprost and timolol | 18 | 720 | £348 | -6.2% ▼ |
| Cocois | 18 | 1,840 | £278 | +31.1% ▲ |
| Linaclotide | 17 | 1,008 | £1.3K | -6.9% ▼ |
| Olmesartan medoxomil | 17 | 1,092 | £38 | -75.3% ▼ |
| Insulin glulisine | 17 | 63 | £698 | -20.7% ▼ |
| Cinacalcet hydrochloride | 17 | 560 | £2.7K | -26.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.